1
van Leent, Merlijn W. J., Stevanovic, Jelena, Jansman, Frank G., Beinema, Maarten J., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
2
Dunnewind, Tom, Dvortsin, Evgeni P., Smeets, Hugo M., Konijn, Rob M., Bos, Jens H. J., de Boer, Pieter T., van den bergh, Joop P., Postma, Maarten J.
Veröffentlicht in: Dunnewind , T , Dvortsin , E P , Smeets , H M , Konijn , R M , Bos , J H J , de Boer , P T , van den bergh , J P & Postma , M J 2017 , ' Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands ' , Value in Health , vol. 20 , no. 6 , pp. 762-768 . https://doi.org/10.1016/j.jval.2017.02.006;
2017
Veröffentlicht in: Dunnewind , T , Dvortsin , E P , Smeets , H M , Konijn , R M , Bos , J H J , de Boer , P T , van den bergh , J P & Postma , M J 2017 , ' Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands ' , Value in Health , vol. 20 , no. 6 , pp. 762-768 . https://doi.org/10.1016/j.jval.2017.02.006;
2017
3
Boersma, Cornelis, Carides, George W., Atthobari, Jarir, Voors, Adriaan A., Postma, Maarten J.
Veröffentlicht in: Boersma , C , Carides , G W , Atthobari , J , Voors , A A & Postma , M J 2007 , ' An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy : Results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands ' , Clinical Therapeutics , vol. 29 , no. 5 , pp. 963-971 . https://doi.org/10.1016/j.clinthera.2007.05.014;
2007
Veröffentlicht in: Boersma , C , Carides , G W , Atthobari , J , Voors , A A & Postma , M J 2007 , ' An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy : Results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands ' , Clinical Therapeutics , vol. 29 , no. 5 , pp. 963-971 . https://doi.org/10.1016/j.clinthera.2007.05.014;
2007
4
de Vries, Robin, Klok, Rogier M., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Veröffentlicht in: de Vries , R , Klok , R M , Brouwers , J R B J & Postma , M J 2009 , ' Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands : The impact of varying the discount rate for health ' , Vaccine , vol. 27 , no. 6 , pp. 846-852 . https://doi.org/10.1016/j.vaccine.2008.11.081;
2009
Veröffentlicht in: de Vries , R , Klok , R M , Brouwers , J R B J & Postma , M J 2009 , ' Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands : The impact of varying the discount rate for health ' , Vaccine , vol. 27 , no. 6 , pp. 846-852 . https://doi.org/10.1016/j.vaccine.2008.11.081;
2009
5
Postma, Maarten J., Novak, Annoesjka, Scheijbeler, Huib W. K. F. H., Gyldmark, Marlene, van Genugten, Marianne L. L., Wilschut, Jan C.
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
6
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
7
Rozenbaum, Mark H., van Hoek, Albert Jan, Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
8
Jacobs, Maartje S., Kaasenbrood, Femke, Postma, Maarten J., van Hulst, Marinus, Tieleman, Robert G.
Veröffentlicht in: Jacobs , M S , Kaasenbrood , F , Postma , M J , van Hulst , M & Tieleman , R G 2018 , ' Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands ' , Europace , vol. 20 , no. 1 , pp. 12-18 . https://doi.org/10.1093/europace/euw285;
2018
Veröffentlicht in: Jacobs , M S , Kaasenbrood , F , Postma , M J , van Hulst , M & Tieleman , R G 2018 , ' Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands ' , Europace , vol. 20 , no. 1 , pp. 12-18 . https://doi.org/10.1093/europace/euw285;
2018
9
de Vries, Folgerdiena M., Denig, Petra, Visser, Sipke T., Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
10
Setiawan, Didik, Luttjeboer, Jos, Westra, Tjalke Arend, Wilschut, Jan C., Suwantika, Auliya A., Daemen, Toos, Atthobari, Jarir, Wilffert, Bob, Postma, Maarten J.
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015